Topics

Rerouting Your Risk-Based Monitoring Strategy: Overcoming Implementation Roadblocks with New Technologies and Approaches, Upcoming Webinar Hosted by Xtalks

09:00 EDT 13 Sep 2019 | PR Web

The need for safer, more efficient and higher quality clinical research requires drug sponsors to consider modifying their risk-based monitoring strategy. Join this free webinar to learn how eClinical technologies such as eCOA and ePRO fit into the development of a robust risk-based monitoring strategy.

TORONTO (PRWEB) September 13, 2019

Over the last decade, the drug development industry has realized the benefits of monitoring trial conduct, safety, data integrity, compliance and enrollment through improving risk-based monitoring (RBM) methods. As a result, we are seeing several recommended changes in our approach to research.

But, for various reasons — including the potential for change to jeopardize approvals — drug sponsors have been slow to adopt these innovative research methods, and the lag is costing the pharmaceutical industry huge amounts of both time and money.

Join Jonathan Andrus, Chief Business Officer at Clinical Ink in a live webinar on Wednesday, September 25, 2019 at 10am EDT (3pm BST/UK) to hear about adopting a comprehensive RBM strategy supported by today’s newest data integration and management technologies.

His discussion will also include:

  • The advantages of using eSource systems, including ePRO and eCOA, for capturing data directly from the patient
  • The impact of time and cost savings associated with direct data capture (DDC) including reducing site monitoring visit frequency and eliminating source document verification and review
  • The power of on-demand data and a complete audit trail in study planning, decision-making and regulatory submission

For more information or to register for this free event, visit Rerouting Your Risk-Based Monitoring Strategy: Overcoming Implementation Roadblocks with New Technologies and Approaches.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

For the original version on PRWeb visit: https://www.prweb.com/releases/rerouting_your_risk_based_monitoring_strategy_overcoming_implementation_roadblocks_with_new_technologies_and_approaches_upcoming_webinar_hosted_by_xtalks/prweb16571807.htm

NEXT ARTICLE

More From BioPortfolio on "Rerouting Your Risk-Based Monitoring Strategy: Overcoming Implementation Roadblocks with New Technologies and Approaches, Upcoming Webinar Hosted by Xtalks"

Quick Search

Relevant Topics

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...